Dermatology NewsHep B vaccine response varied among youth with inflammatory, autoimmune disordersAugust 12, 2021PediatricsInfectious DiseasesAutoimmune Diseases
Dermatology NewsCAR T-cell therapy drives refractory SLE into remissionAugust 12, 2021Autoimmune Diseases
Dermatology NewsFDA approves anifrolumab (Saphnelo) as first new lupus treatment in more than 10 yearsAugust 2, 2021Autoimmune Diseases
Dermatology NewsCOVID-19 vaccination does not increase risk of flare in patients with lupusJuly 27, 2021COVID-19 UpdatesAutoimmune Diseases
Dermatology NewsAutoinflammatory diseases ‘not so rare after all,’ expert saysJuly 22, 2021Autoimmune DiseasesPediatricsRare Diseases
Dermatology NewsFDA approves intravenous immunoglobulin for dermatomyositisJuly 21, 2021Autoimmune DiseasesRare Diseases
Dermatology NewsNeuropsychiatric event etiology in lupus helps define predictors, outcomesJuly 9, 2021Autoimmune Diseases
Dermatology NewsLupus images fall short on diverse examplesJune 17, 2021Diversity in MedicineAutoimmune Diseases
Dermatology NewsNew biomarkers may predict interstitial lung disease progression in patients with systemic sclerosisJune 16, 2021Autoimmune DiseasesRare Diseases
Dermatology NewsLenabasum missed mark for systemic sclerosis but may show promise for adjunctive therapyJune 11, 2021Autoimmune DiseasesMedical Dermatology
Reexamining the Role of Diet in DermatologyJune 8, 2021RosaceaAutoimmune DiseasesAtopic DermatitisAcnePsoriasisNonmelanoma Skin Cancer
Dermatology NewsBEAT-LUPUS: Belimumab after rituximab delays severe flaresJune 3, 2021Autoimmune Diseases
Dermatology NewsIntravenous immunoglobulin controls dermatomyositis in phase 3 trialJune 3, 2021Autoimmune DiseasesMedical DermatologyRare Diseases
Ulcerative Heliotrope Rash in Antimelanoma Differentiation–Associated Gene 5 DermatomyositisMay 24, 2021Autoimmune Diseases